![Man ultramarathon runner in the mountains he trains at sunset](https://d2csxpduxe849s.cloudfront.net/media/E32629C6-9347-4F84-81FEAEF7BFA342B3/0B4B1380-42EB-4FD5-9D7E2DBC603E79F8/webimage-C4875379-1478-416F-B03DF68FE3D8DBB5.png)
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
CASE REPORT article
Front. Immunol.
Sec. Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1529745
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
We reported a rare case of pro-B acute adult lymphoblastic leukemia (pro-B ALL) accompanied by severe refractory plaque psoriasis treated with autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy. An 18-year-old man was diagnosed of pro-B ALL with a known history of mild plaque psoriasis for 1 years. After induction chemotherapy, his psoriasis began to worsen. Extensive erythema and desquamation developed on the whole body with severe plaque psoriasis on the knees and elbows, which did not response to topical therapy. The application of CAR T-cell therapy not only enabled him to achieve deep complete remission (CR), but also allowed his skin lesions to completely subside. The successful treatment supports a potential pathogenic link between B cells and psoriasis which could provide a new option to overcome refractory psoriasis.
Keywords: pro-B ALL, Psoriasis, CD19 CAR T cells, B cell, therapeutic targets
Received: 17 Nov 2024; Accepted: 13 Feb 2025.
Copyright: © 2025 Zhang, Zhang, Yang, Gong, Li, Wei, Xue, Wei, Wang and Qiu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Shaowei Qiu, Peking Union Medical College Hospital (CAMS), Beijing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.